A detailed history of Northern Trust Corp transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 622,428 shares of STRO stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
622,428
Previous 502,648 23.83%
Holding current value
$1.21 Million
Previous $1.47 Million 46.26%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.88 - $5.01 $344,966 - $600,097
119,780 Added 23.83%
622,428 $2.15 Million
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $47,490 - $86,687
16,264 Added 3.34%
502,648 $1.47 Million
Q1 2024

May 14, 2024

BUY
$3.27 - $5.65 $17,004 - $29,380
5,200 Added 1.08%
486,384 $2.75 Million
Q4 2023

Feb 13, 2024

SELL
$2.07 - $4.54 $9,600 - $21,056
-4,638 Reduced 0.95%
481,184 $2.06 Million
Q3 2023

Nov 13, 2023

BUY
$3.29 - $4.9 $9,047 - $13,475
2,750 Added 0.57%
485,822 $1.69 Million
Q2 2023

Aug 11, 2023

BUY
$4.25 - $5.88 $119,701 - $165,610
28,165 Added 6.19%
483,072 $2.25 Million
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $25,338 - $47,793
-5,656 Reduced 1.23%
454,907 $2.1 Million
Q4 2022

Feb 13, 2023

BUY
$5.41 - $8.08 $291,009 - $434,631
53,791 Added 13.22%
460,563 $3.72 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $154,024 - $211,821
29,792 Added 7.9%
406,772 $2.26 Million
Q2 2022

Aug 12, 2022

SELL
$3.41 - $8.95 $47,890 - $125,693
-14,044 Reduced 3.59%
376,980 $1.96 Million
Q1 2022

May 13, 2022

SELL
$7.78 - $15.31 $1.2 Million - $2.36 Million
-154,200 Reduced 28.28%
391,024 $3.21 Million
Q4 2021

Feb 08, 2022

BUY
$14.25 - $23.53 $131,100 - $216,476
9,200 Added 1.72%
545,224 $8.11 Million
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $310,170 - $411,232
-18,375 Reduced 3.31%
536,024 $10.1 Million
Q2 2021

Aug 13, 2021

BUY
$18.03 - $23.82 $3.79 Million - $5 Million
210,078 Added 61.01%
554,399 $10.3 Million
Q1 2021

May 12, 2021

BUY
$20.29 - $27.54 $609,613 - $827,439
30,045 Added 9.56%
344,321 $7.84 Million
Q4 2020

Feb 11, 2021

BUY
$10.16 - $23.98 $949,624 - $2.24 Million
93,467 Added 42.33%
314,276 $6.82 Million
Q3 2020

Nov 16, 2020

BUY
$7.44 - $13.15 $12,342 - $21,815
1,659 Added 0.76%
220,809 $2.22 Million
Q2 2020

Aug 14, 2020

BUY
$7.24 - $11.05 $662,228 - $1.01 Million
91,468 Added 71.64%
219,150 $1.7 Million
Q1 2020

May 14, 2020

BUY
$6.19 - $12.16 $34,057 - $66,904
5,502 Added 4.5%
127,682 $1.3 Million
Q4 2019

Feb 14, 2020

BUY
$8.15 - $11.39 $6,161 - $8,610
756 Added 0.62%
122,180 $1.34 Million
Q3 2019

Nov 13, 2019

BUY
$7.91 - $11.76 $329,427 - $489,768
41,647 Added 52.2%
121,424 $1.1 Million
Q2 2019

Aug 13, 2019

BUY
$9.69 - $12.23 $47,577 - $60,049
4,910 Added 6.56%
79,777 $907,000
Q1 2019

May 13, 2019

BUY
$8.8 - $11.87 $92,848 - $125,240
10,551 Added 16.4%
74,867 $852,000
Q4 2018

Feb 12, 2019

BUY
$8.69 - $14.85 $558,906 - $955,092
64,316 New
64,316 $580,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $101M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.